NETRIS Pharma is pleased to announce the arrival of Frédéric Le Bras, MD; as the new company Chief Medical Officer. Graduated from René Descartes University in Paris, Frédéric obtained his...
Read More
NETRIS Pharma will attend the 2019 Bio-Europe conference in Hamburg, Germany (November 11th-13th). Our team members will be pleased to meet with you and discuss Business Development and investment opportunities. Please...
Read More
Dr Philippe Cassier, Principal Investigator of NETRIS Pharma Phase 1 dose-escalation clinical trial on solid tumors, will present the results of the trial at ESMO Conference in Barcelona. The presentation...
Read More
NETRIS Pharma will attend the Colloque on Women Cancer in Paris (March 30th, 2019). In partnership with “La Ligue contre le Cancer” Association, the following theme will be discussed by…
NETRIS Pharma will attend the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California (January 07th-10th, 2019). Our team members attending the event will be pleased to meet you for…
NETRIS Pharma will attend PEGS 2018 event in Boston, MA (April 30th-May 04th). Our CEO, Pr. Patrick Mehlen, will give a presentation on April 30th within the Oncology stream – Antibodies…
NETRIS Pharma will attend the BIO-Europe Spring 2018 event in Amsterdam, Netherlands (March 12th-14th). Our team members attending the event will be pleased to meet you for discussing opportunities with…
NETRIS Pharma will attend the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, California (January 08th-11th, 2018). Our team members attending the event will be pleased to meet you…